FDA Drug Shortages: Spironolactone Tablets, USP

 

Spironolactone Tablets, USP
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Company Contact Information:
800-828-9393

 

Presentation Posting Date Related Information
25 mg, bottle of 100 (NDC 0603-5763-21) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
25 mg, bottle of 500 (NDC 0603-5763-28) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
25 mg, bottle of 1000 (NDC 0603-5763-32) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
25 mg, bottle of 2500 (NDC 0603-5763-30) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
50 mg, bottle of 100 (NDC 0603-5764-21) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
50 mg, bottle of 500 (NDC 0603-5764-28) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
100 mg, bottle of 100 (NDC 0603-5765-21) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.
100 mg, bottle of 500 (NDC 0603-5765-28) 04/19/2019 Par has made a business decision to permanently discontinue the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English

To read more Press Release articles, click here.